Tilray Brands Inc vs Vanguard Growth Index Fund ETF — how do they compare? Tilray Brands Inc trades at $3.54 (market cap $530.54M), while Vanguard Growth Index Fund ETF trades at $91.97 (market cap $384.60B). The key difference: Vanguard Growth Index Fund ETF is far larger — about 724.9× Tilray Brands Inc's market cap, and Vanguard Growth Index Fund ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Vanguard Growth Index Fund ETF for 47 Days on average.
| TLRY | VUG | |
|---|---|---|
Market Cap | $530.54M | $384.60B |
Volume | 9,099,075 | 5,662,307 |
Sector | Health | Sector/Thematic |
52-Week High | $21.00 | $92.64 |
52-Week Low | $3.57 | $70.00 |
Typical Hold Time | 31 Days | 47 Days |
Enterprise Value | $684.46M | — |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.54, down 4.71% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows negative technical momentum with consecutive earnings misses and widening losses despite revenue growth. Recent financials reveal a net loss of $2.19B for 2025, though analyst consensus maintains a $65.01 price target with 25% buy ratings. Business developments include new product launches and leadership changes under Tilray's expanded beverage portfolio.
Outlook remains challenged by profitability concerns and high debt, but potential cannabis regulatory shifts could catalyze recovery. Investment opportunity hinges on execution improvement and market expansion, while risks include sustained cash burn and competitive pressures in the cannabis sector.
VUG trades at $91.97, down 0.49% with a bullish technical signal supported by moving averages. The ETF holds dominant positions in mega-cap tech stocks including Nvidia, Apple, and Microsoft, which comprise over 36% of holdings. Recent financial media coverage highlights VUG's historical annual returns averaging 11-12% since its 2004 inception, positioning it as a long-term growth vehicle for investors with multi-decade horizons.
The outlook remains positive for long-term investors seeking growth exposure, though concentration in technology stocks presents sector-specific risks. Current technical levels show support at $89-91 with resistance at $92-94. The neutral oscillator readings suggest potential for consolidation near current levels before further directional movement.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →